PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel

View source ↗

Summary

The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) concluded there is no evidence of a change in the known risk of neutropenic enterocolitis with doce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer
• Other Cancers Treated with Docetaxel

Drugs mentioned

• DOCETAXEL (DOCETAXEL)